ASX Announcement

Phase 1 IRX-616a Trial Advances - Positive Safety Review

Published: 17/04/26, 09:50am (AEST)2 pages
Nexalis Therapeutics
NX1:ASXHealthcare

Recent NX1 Announcements

Price Sensitive only